Highlights
NASDAQ: NK       Nantkwest Inc CS
Last Price Today's Change   Day's Range   Trading Volume
2.20   +0.28 (14.58%)  1.92 - 2.30  885,562

Overview

 
Avg Volume (4 weeks):356,821
4 Weeks Range:1.09 - 2.30
4 Weeks Price Volatility (%):
91.74%
52 Weeks Range:0.93 - 2.30
52 Weeks Price Volatility (%):
92.70%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S territories.

  Be the first to like this.
 


 

3627  2103  325  2916 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.35+1.68 
 CHK 0.791+0.046 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers